CATX
Perspective Therapeutics
$2.82
−$0.09 (−3.09%)Jul 27, 2026
Key metrics
The numbers that frame CATX today
- Market cap
- $321.61M
- P/E (TTM)
- -2.9
- EV / FCF
- -2.5
- Gross margin
- 100%
- EV / Sales
- 439.9
- ROIC
- -50.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.96
- 52wk High
- $6.16
Growth
Revenue and earnings trend for CATX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CATX
Is Perspective Therapeutics a good buy?
No. Perspective Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Perspective Therapeutics is selling at a very high price.
What is the market capitalization of CATX?
Perspective Therapeutics's market capitalization is $321.61M.
What is the P/E ratio for CATX stock?
Perspective Therapeutics's current P/E ratio is -2.9.
What is the 52-week high for CATX stock?
The 52-week high for Perspective Therapeutics is $6.16. The current close of $2.82 is 54.2% below that high.
What is the 52-week low for CATX stock?
The 52-week low for Perspective Therapeutics is $1.96. The current close of $2.82 is 43.9% above that low.
Does CATX stock pay dividends?
Perspective Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CATX?
Perspective Therapeutics's Debt / Equity ratio is 0.01.